News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
JONAS JEFFREY M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/02/2023 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 3,399 shares
@ $194.78, valued at
$662.1k
Sold 6,301 shares
@ $195.61, valued at
$1.2M
Sold 3,110 shares
@ $196.59, valued at
$611.4k
Sold 400 shares
@ $197.66, valued at
$79.1k
Sold 600 shares
@ $198.41, valued at
$119k
Exercised 13,810 options to buy
@ $7.27, valued at
$100.4k
|
|
| 07/05/2023 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 234 shares
@ $214.61, valued at
$50.2k
Sold 7,966 shares
@ $215.91, valued at
$1.7M
Sold 3,201 shares
@ $216.78, valued at
$693.9k
Sold 2,409 shares
@ $217.82, valued at
$524.7k
Exercised 13,810 options to buy
@ $7.27, valued at
$100.4k
|
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 06/12/2023 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 25,000 options to buy
@ $4.83, valued at
$120.8k
|
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 5,100 shares
@ $0
Paid exercise price by delivering 1,427 shares
@ $44.16, valued at
$63k
|
|
| 01/05/2023 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Exercised 2,501 options to buy
@ $28.63, valued at
$71.6k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| JONAS JEFFREY M (Chief Innovation Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Exercised 4,000 options to buy
@ $0.45, valued at
$1.8k
|
|
| 02/15/2022 |
4
| JONAS JEFFREY M (Chief Innovation Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 15,200 options to buy
@ $43.04, valued at
$654.2k
|
|
| 10/21/2021 |
4
| JONAS JEFFREY M (Chief Innovation Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Paid exercise price by delivering 4,374 shares
@ $40.29, valued at
$176.2k
|
|
| 06/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 15,000 options to buy
@ $26.59, valued at
$398.9k
|
|
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| JONAS JEFFREY M (Chief Innovation Officer) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Exercised 1,800 options to buy
@ $0.45, valued at
$810 |
|
| 01/13/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 06/15/2020 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 52,000 options to buy
@ $19, valued at
$988k
|
|
| 06/11/2020 |
3
| JONAS JEFFREY M (Director) has filed a Form 3 on Generation Bio Co. |
| 06/08/2020 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $97.59, valued at
$1.2M
|
|
| 04/30/2020 |
4
| JONAS JEFFREY M (President & CEO) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 15,385 options to buy
@ $39.87, valued at
$613.4k
|
|
| 02/14/2020 |
4
| JONAS JEFFREY M (President & CEO) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $68.87, valued at
$3.4M
|
|
| 02/14/2020 |
4
| JONAS JEFFREY M (President & CEO) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 50,000 options to buy
@ $68.87, valued at
$3.4M
|
|
| 12/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2019 |
4
| JONAS JEFFREY M (President & CEO) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Exercised 27,000 options to buy
@ $0.45, valued at
$12.2k
|
|
| 07/01/2019 |
4
| JONAS JEFFREY M (Director) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Granted 16,250 options to buy
@ $16, valued at
$260k
|
|
| 06/27/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2019 |
4
| JONAS JEFFREY M (President & CEO) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Sold 25,510 shares
@ $173.6156, valued at
$4.4M
Sold 28,293 shares
@ $174.4837, valued at
$4.9M
Sold 16,651 shares
@ $175.718, valued at
$2.9M
Sold 11,662 shares
@ $176.4426, valued at
$2.1M
Sold 2,545 shares
@ $177.6162, valued at
$452k
Sold 200 shares
@ $169.16, valued at
$33.8k
Sold 400 shares
@ $170.395, valued at
$68.2k
Sold 475 shares
@ $171.3906, valued at
$81.4k
Exercised 35,736 options to buy
@ $0.45, valued at
$16.1k
|
|
|
|
|